Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells
- 1 July 2003
- journal article
- review article
- Published by Elsevier in Transplant Immunology
- Vol. 11 (3-4) , 295-306
- https://doi.org/10.1016/s0966-3274(03)00048-0
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Dendritic cell-based vaccines and therapies for cancerExpert Opinion on Biological Therapy, 2002
- Effective expression of small interfering RNA in human cellsNature Biotechnology, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Dendritic Cell-Based Vaccination Strategies: Induction of Protective Immunity against LeishmaniasisImmunobiology, 2001
- Immune Response to Intragraft Antigen in Draining Lymph Nodes After Corneal Transplantation Is Mediated by Interleukin-12Journal of Interferon & Cytokine Research, 2001
- CD14+ Monocytes as Dendritic Cell Precursors: Diverse Maturation-Inducing Pathways Lead to Common Activation of NF-kB/RelBCritical Reviews in Immunology, 2001
- Prolongation of Cardiac Allograft Survival Using Dendritic Cells Treated with NF-κB Decoy OligodeoxyribonucleotidesMolecular Therapy, 2000
- CYCLOSPORINE A INHIBITS THE EXPRESSION OF COSTIMULATORY MOLECULES ON IN VITRO-GENERATED DENDRITIC CELLSTransplantation, 1999
- Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic TargetThe Journal of Clinical Pharmacology, 1998
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993